Skip to main content

Market Overview

Benzinga's Top Upgrades, Downgrades For March 5, 2020

Share:

Upgrades

  • For Monolithic Power Systems Inc (NASDAQ: MPWR), Needham upgraded the stock from Hold to Buy. In the fourth quarter, Monolithic Power Systems showed an EPS of $1.04, compared to $0.99 from the year-ago quarter. The stock has a 52-week-high of $193.10 and a 52-week-low of $114.84. Monolithic Power Systems's stock last closed at $171.54 per share.
  • Needham changed the rating for Silicon Laboratories Inc (NASDAQ: SLAB) from Hold to Buy. Silicon Laboratories earned $0.84 in the fourth quarter, compared to $0.91 in the year-ago quarter. The stock has a 52-week-high of $122.90 and a 52-week-low of $77.08. Silicon Laboratories's stock last closed at $92.06 per share.
  • UBS upgraded the stock for Cheniere Energy Partners LP (AMEX: CQP) from Neutral to Buy. In the fourth quarter, Cheniere Energy Partners showed an EPS of $0.87, compared to $0.69 from the year-ago quarter. The stock has a 52-week-high of $49.30 and a 52-week-low of $31.38. Cheniere Energy Partners's stock last closed at $32.54 per share.
  • DA Davidson changed the rating for Cars.com Inc (NYSE: CARS) from Neutral to Buy. For the fourth quarter, Cars.com had an EPS of $0.63, compared to year-ago quarter EPS of $0.50. The stock has a 52-week-high of $24.43 and a 52-week-low of $7.29. Cars.com's stock last closed at $7.77 per share.
  • For Dycom Industries Inc (NYSE: DY), DA Davidson upgraded the stock from Neutral to Buy. Dycom Industries earned ($0.23) in the fourth quarter, compared to $0.10 in the year-ago quarter. The stock has a 52-week-high of $60.55 and a 52-week-low of $24.15. Dycom Industries's stock last closed at $25.70 per share.
  • Wells Fargo upgraded the stock for NovoCure Ltd (NASDAQ: NVCR) from Equal-Weight to Overweight. For the fourth quarter, NovoCure had an EPS of $0.04, compared to year-ago quarter EPS of ($0.17). The stock has a 52-week-high of $98.84 and a 52-week-low of $41.51. NovoCure's stock last closed at $73.62 per share.
  • MKM Partners upgraded the stock for Snap Inc (NYSE: SNAP) from Neutral to Buy. For the fourth quarter, Snap had an EPS of $0.03, compared to year-ago quarter EPS of ($0.04). The stock has a 52-week-high of $19.75 and a 52-week-low of $9.16. Snap's stock last closed at $13.62 per share.
  • Canaccord Genuity upgraded the stock for Skyworks Solutions Inc (NASDAQ: SWKS) from Hold to Buy. Skyworks Solutions earned $1.68 in the first quarter, compared to $1.83 in the year-ago quarter. The stock has a 52-week-high of $128.48 and a 52-week-low of $66.29. Skyworks Solutions's stock last closed at $103.36 per share.
  • Compass Point upgraded the stock for First American Financial Corp (NYSE: FAF) from Neutral to Buy. In the fourth quarter, First American Financial showed an EPS of $1.80, compared to $1.27 from the year-ago quarter. The stock has a 52-week-high of $66.40 and a 52-week-low of $48.30. First American Financial's stock last closed at $64.28 per share.
  • For Gildan Activewear Inc (NYSE: GIL), ScotiaBank upgraded the stock from Sector Perform to Sector Outperform. For the fourth quarter, Gildan Activewear had an EPS of $0.41, compared to year-ago quarter EPS of $0.43. The stock has a 52-week-high of $40.40 and a 52-week-low of $23.45. Gildan Activewear's stock last closed at $24.72 per share.
  • Deutsche Bank upgraded the stock for Dollar Tree Inc (NASDAQ: DLTR) from Hold to Buy. For the fourth quarter, Dollar Tree had an EPS of $1.79, compared to year-ago quarter EPS of $1.93. The stock has a 52-week-high of $119.71 and a 52-week-low of $78.07. Dollar Tree's stock last closed at $78.91 per share.
  • UBS changed the rating for RELX PLC (NYSE: RELX) from Sell to Neutral. The stock has a 52-week-high of $27.25 and a 52-week-low of $21.20. RELX's stock last closed at $25.11 per share.
  • Bernstein changed the rating for British American Tobacco PLC (NYSE: BTI) from Market Perform to Outperform. The stock has a 52-week-high of $45.64 and a 52-week-low of $33.73. British American Tobacco's stock last closed at $42.10 per share.
  • Credit Suisse changed the rating for Campbell Soup Co (NYSE: CPB) from Underperform to Neutral. Campbell Soup earned $0.72 in the second quarter, compared to $0.77 in the year-ago quarter. The stock has a 52-week-high of $52.83 and a 52-week-low of $35.03. Campbell Soup's stock last closed at $52.83 per share.

 

Downgrades

  • Stephens & Co. changed the rating for Zoom Video Communications Inc (NASDAQ: ZM) from Overweight to Equal-Weight. Interestingly, in the fourth quarter, Zoom Video Communications's EPS was $0.15. The stock has a 52-week-high of $121.93 and a 52-week-low of $59.94. Zoom Video Communications's stock last closed at $116.80 per share.
  • For Check Point Software Technologies Ltd (NASDAQ: CHKP), Goldman Sachs downgraded the stock from Neutral to Sell. Check Point Software Tech earned $2.02 in the fourth quarter, compared to $1.68 in the year-ago quarter. The stock has a 52-week-high of $132.75 and a 52-week-low of $98.91. Check Point Software Tech's stock last closed at $104.00 per share.
  • For Moderna Inc (NASDAQ: MRNA), B of A Securities downgraded the stock from Buy to Neutral. For the fourth quarter, Moderna had an EPS of ($0.37), compared to year-ago quarter EPS of ($0.43). The stock has a 52-week-high of $36.00 and a 52-week-low of $11.54. Moderna's stock last closed at $27.49 per share.
  • B of A Securities downgraded the stock for Alexion Pharmaceuticals Inc (NASDAQ: ALXN) from Buy to Neutral. For the fourth quarter, Alexion Pharmaceuticals had an EPS of $2.71, compared to year-ago quarter EPS of $2.14. The stock has a 52-week-high of $141.86 and a 52-week-low of $89.70. Alexion Pharmaceuticals's stock last closed at $97.22 per share.
  • BTIG Research changed the rating for Cellular Biomedicine Group Inc (NASDAQ: CBMG) from Buy to Neutral. Cellular Biomedicine Gr earned ($0.65) in the fourth quarter, compared to ($0.44) in the year-ago quarter. The stock has a 52-week-high of $19.86 and a 52-week-low of $10.98. Cellular Biomedicine Gr's stock last closed at $16.86 per share.
  • For State Street Corporation (NYSE: STT), Deutsche Bank downgraded the stock from Buy to Hold. For the fourth quarter, State Street had an EPS of $1.98, compared to year-ago quarter EPS of $1.68. The stock has a 52-week-high of $85.89 and a 52-week-low of $48.62. State Street's stock last closed at $67.04 per share.

 

Initiations

  • With a rating of Neutral, B of A Securities initiated coverage on Intercept Pharmaceuticals Inc (NASDAQ: ICPT). The price target is set at $111.00 for Intercept Pharmaceuticals. For the fourth quarter, Intercept Pharmaceuticals had an EPS of ($2.99), compared to year-ago quarter EPS of ($2.97). The stock has a 52-week-high of $125.00 and a 52-week-low of $56.76. Intercept Pharmaceuticals's stock last closed at $95.10 per share.
  • With a rating of Buy, Benchmark initiated coverage on Universal Forest Products Inc (NASDAQ: UFPI). The price target is set at $57.00 for Universal Forest Products. For the fourth quarter, Universal Forest Products had an EPS of $0.61, compared to year-ago quarter EPS of $0.50. The stock has a 52-week-high of $58.10 and a 52-week-low of $29.00. Universal Forest Products's stock last closed at $50.07 per share.
  • With a rating of Buy, Citigroup initiated coverage on iRhythm Technologies Inc (NASDAQ: IRTC). The price target is set at $120.00 for iRhythm Technologies. In the fourth quarter, iRhythm Technologies showed an EPS of ($0.65), compared to ($0.48) from the year-ago quarter. The stock has a 52-week-high of $99.64 and a 52-week-low of $56.24. iRhythm Technologies's stock last closed at $99.35 per share.
  • Citigroup initiated coverage on Penumbra Inc (NYSE: PEN) with a Buy rating. The price target for Penumbra is set at $200.00. For the fourth quarter, Penumbra had an EPS of $0.22, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $194.93 and a 52-week-low of $122.40. Penumbra's stock last closed at $177.56 per share.
  • With a rating of Sell, Citigroup initiated coverage on Glaukos Corp (NYSE: GKOS). The price target is set at $40.00 for Glaukos. Glaukos earned ($0.06) in the fourth quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $84.65 and a 52-week-low of $40.00. Glaukos's stock last closed at $42.25 per share.
  • With a rating of Buy, Citigroup initiated coverage on Zimmer Biomet Holdings Inc (NYSE: ZBH). The price target is set at $168.00 for Zimmer Biomet Holdings. In the fourth quarter, Zimmer Biomet Holdings showed an EPS of $2.30, compared to $2.18 from the year-ago quarter. The stock has a 52-week-high of $161.11 and a 52-week-low of $111.17. Zimmer Biomet Holdings's stock last closed at $138.02 per share.
  • With a rating of Buy, Citigroup initiated coverage on DexCom Inc (NASDAQ: DXCM). The price target is set at $330.00 for DexCom. In the fourth quarter, DexCom showed an EPS of $1.15, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $306.71 and a 52-week-low of $107.44. DexCom's stock last closed at $283.87 per share.
  • With a rating of Neutral, Citigroup initiated coverage on Becton, Dickinson and Co (NYSE: BDX). The price target is set at $260.00 for Becton, Dickinson. In the first quarter, Becton, Dickinson showed an EPS of $2.65, compared to $2.70 from the year-ago quarter. The stock has a 52-week-high of $286.72 and a 52-week-low of $221.47. Becton, Dickinson's stock last closed at $246.98 per share.
  • With a rating of Neutral, Citigroup initiated coverage on Alcon Inc (NYSE: ALC). The price target is set at $63.00 for Alcon. In the fourth quarter, Alcon earned $0.45. The stock has a 52-week-high of $65.37 and a 52-week-low of $53.78. Alcon's stock last closed at $63.01 per share.
  • With a rating of Neutral, Citigroup initiated coverage on The Cooper Companies Inc (NYSE: COO). The price target is set at $360.00 for Cooper Companies. In the first quarter, Cooper Companies showed an EPS of \ No EPS Value , compared to $2.88 from the year-ago quarter. The stock has a 52-week-high of $365.68 and a 52-week-low of $278.50. Cooper Companies's stock last closed at $338.25 per share.
  • With a rating of Buy, Citigroup initiated coverage on Stryker Corp (NYSE: SYK). The price target is set at $235.00 for Stryker. In the fourth quarter, Stryker showed an EPS of $2.49, compared to $2.18 from the year-ago quarter. The stock has a 52-week-high of $226.30 and a 52-week-low of $174.84. Stryker's stock last closed at $198.40 per share.
  • With a rating of Buy, Citigroup initiated coverage on Insulet Corp (NASDAQ: PODD). The price target is set at $220.00 for Insulet. In the fourth quarter, Insulet showed an EPS of $0.08, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $219.85 and a 52-week-low of $80.43. Insulet's stock last closed at $179.05 per share.
  • Citigroup initiated coverage on NuVasive Inc (NASDAQ: NUVA) with a Neutral rating. The price target for NuVasive is set at $68.00. NuVasive earned $0.73 in the fourth quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $81.91 and a 52-week-low of $52.69. NuVasive's stock last closed at $64.15 per share.
  • Citigroup initiated coverage on Edwards Lifesciences Corp (NYSE: EW) with a Buy rating. The price target for Edwards Lifesciences is set at $252.00. Edwards Lifesciences earned $1.46 in the fourth quarter, compared to $1.17 in the year-ago quarter. The stock has a 52-week-high of $247.64 and a 52-week-low of $165.69. Edwards Lifesciences's stock last closed at $217.37 per share.
  • Citigroup initiated coverage on Baxter International Inc (NYSE: BAX) with a Neutral rating. The price target for Baxter International is set at $94.00. For the fourth quarter, Baxter International had an EPS of \ No EPS Value , compared to year-ago quarter EPS of $0.78. The stock has a 52-week-high of $95.00 and a 52-week-low of $72.42. Baxter International's stock last closed at $91.04 per share.
  • Citigroup initiated coverage on Abbott Laboratories (NYSE: ABT) with a Buy rating. The price target for Abbott Laboratories is set at $96.00. Abbott Laboratories earned $0.95 in the fourth quarter, compared to $0.81 in the year-ago quarter. The stock has a 52-week-high of $92.45 and a 52-week-low of $72.36. Abbott Laboratories's stock last closed at $82.05 per share.
  • With a rating of Hold, Stifel Nicolaus initiated coverage on CRISPR Therapeutics AG (NASDAQ: CRSP). The price target is set at $52.00 for CRISPR Therapeutics. For the fourth quarter, CRISPR Therapeutics had an EPS of $0.51, compared to year-ago quarter EPS of ($0.92). The stock has a 52-week-high of $74.00 and a 52-week-low of $33.55. CRISPR Therapeutics's stock last closed at $53.26 per share.
  • With a rating of Buy, Citigroup initiated coverage on Johnson & Johnson (NYSE: JNJ). The price target is set at $163.00 for Johnson & Johnson. Johnson & Johnson earned $1.88 in the fourth quarter, compared to $1.97 in the year-ago quarter. The stock has a 52-week-high of $154.50 and a 52-week-low of $126.10. Johnson & Johnson's stock last closed at $143.53 per share.
  • With a rating of Buy, Citigroup initiated coverage on Medtronic PLC (NYSE: MDT). The price target is set at $124.00 for Medtronic. Medtronic earned $1.44 in the third quarter, compared to $1.29 in the year-ago quarter. The stock has a 52-week-high of $122.15 and a 52-week-low of $82.77. Medtronic's stock last closed at $103.66 per share.
  • Stifel Nicolaus initiated coverage on Precision BioSciences Inc (NASDAQ: DTIL) with a Buy rating. The price target for Precision BioSciences is set at $21.00. In the third quarter, Precision BioSciences earned ($0.41). The stock has a 52-week-high of $23.67 and a 52-week-low of $6.24. Precision BioSciences's stock last closed at $8.11 per share.
 

Related Articles (ABT + ALC)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
PHXSeaport GlobalInitiates Coverage On
AFCGLake StreetInitiates Coverage On29.0
OSSNoble Capital MarketsUpgrades7.0
NCNOGabelli & Co.Upgrades
HAECJS SecuritiesUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com